“…The understanding of the transmission mechanism and risk of infection was achieved when experimental infection with cell-free MDV of feather follicle desquamation epithelium was demonstrated (Beasley et al, 1970;Calnek et al, 1969;Calnek et al, 1970a). The virus was serially passaged in primary kidney cell monolayers and successfully attenuated (Churchill et al, 1969), and given to one-day-old chicks induced protection against the challenge (Calnek et al, 1970b), subsequently also acquired by naturally a virulent strains isolated from turkeys (Witter et al, 1970b) and chickens (Biggs & Milne, 1972;Cho & Kenzy, 1972). Among the isolated a virulent low virulence MDV strains, the CVI 988 vaccines became popular or of (Rispens et al, 1972) and SB-1 (Schat & Calnek, 1978 Marek's disease virus MDV is classified as Gallid Herpesvirus 2, genus Mardivirus, famíly Herpesviridae, subfamíly Alphaherpesvirinae, and divided into three serotypes MDV-1 (RB-1B, Md5 and CVI988), MDV-2 (SB-1 e HPRS24), and the antigenically related Meleagrid Herpesvirus-1 (known as serotype three; herpes vírus of turkeys-strain FC126) (ICTV, 2018;Dunn et al, 2014).…”